Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

The Predictive Ability of Pre-Operative Magnetic Resonance Imaging to Detect Pathological Outcomes in Prostate Cancer

Nason GJ, Selvarajah L, O’Connor EM, O’Kelly J, Considine SW, Moss B, MacMahon D, Heneghan J, Meyer N, Buckley J, O’Regan K, O’Brien MF.

Ir Med J. 2018 Aug 13;111(7):790.

PMID:
30520617
2.

Febrile neutropenia (FN) and pegfilgrastim prophylaxis in breast cancer and non-Hodgkin's lymphoma patients receiving high (> 20%) FN-risk chemotherapy: results from a prospective observational study.

Salmon JP, Smakal M, Karanikiotis C, Wojtukiewicz MZ, Omnes Y, DeCosta L, Wetten S, O'Kelly J.

Support Care Cancer. 2019 Apr;27(4):1449-1457. doi: 10.1007/s00520-018-4473-x. Epub 2018 Sep 26.

PMID:
30259136
3.

A chip off the old block-A case report of gallstone ileus in which identification of a facetted stone was essential in preventing re-laparotomy.

O'Kelly J, Begg P, Anderson D.

Int J Surg Case Rep. 2017;38:95-97. doi: 10.1016/j.ijscr.2017.06.039. Epub 2017 Jun 28.

5.

Factors impacting time to acceptance and publication for peer-reviewed publications.

Toroser D, Carlson J, Robinson M, Gegner J, Girard V, Smette L, Nilsen J, O'Kelly J.

Curr Med Res Opin. 2017 Jul;33(7):1183-1189. doi: 10.1080/03007995.2016.1271778. Epub 2016 Dec 31.

PMID:
27977312
6.

Editorial: Dialogues in Music Therapy and Music Neuroscience: Collaborative Understanding Driving Clinical Advances.

O'Kelly J, Fachner JC, Tervaniemi M.

Front Hum Neurosci. 2016 Nov 22;10:585. eCollection 2016. No abstract available.

7.

Development of the Music Therapy Assessment Tool for Advanced Huntington's Disease: A Pilot Validation Study.

O'Kelly J, Bodak R.

J Music Ther. 2016 Fall;53(3):232-56. doi: 10.1093/jmt/thw006. Epub 2016 Jun 29.

PMID:
27358245
8.

Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor.

Arvedson T, O'Kelly J, Yang BB.

BioDrugs. 2015 Jun;29(3):185-98. doi: 10.1007/s40259-015-0127-4. Review.

9.

Music therapy with disorders of consciousness: current evidence and emergent evidence-based practice.

Magee WL, O'Kelly J.

Ann N Y Acad Sci. 2015 Mar;1337:256-62. doi: 10.1111/nyas.12633.

PMID:
25773642
10.

The critical view of safety in laparoscopic cholecystectomy: towards a national consensus.

O'Kelly JA, De Marchi JA, Joyce WP.

Ir Med J. 2015 Jan;108(1):26. No abstract available.

PMID:
25702354
11.

Neurophysiological and behavioral responses to music therapy in vegetative and minimally conscious States.

O'Kelly J, James L, Palaniappan R, Taborin J, Fachner J, Magee WL.

Front Hum Neurosci. 2013 Dec 25;7:884. doi: 10.3389/fnhum.2013.00884. eCollection 2013.

12.

Measuring coverage in MNCH: challenges in monitoring the proportion of young children with pneumonia who receive antibiotic treatment.

Campbell H, El Arifeen S, Hazir T, O'Kelly J, Bryce J, Rudan I, Qazi SA.

PLoS Med. 2013;10(5):e1001421. doi: 10.1371/journal.pmed.1001421. Epub 2013 May 7. Review.

13.

The complementary role of music therapy in the detection of awareness in disorders of consciousness: an audit of concurrent SMART and MATADOC assessments.

O'Kelly J, Magee WL.

Neuropsychol Rehabil. 2013;23(2):287-98. doi: 10.1080/09602011.2012.753395. Epub 2013 Jan 10.

PMID:
23302033
14.

A naturalistic trial of brief psychodynamic therapy for recurrent major depression.

Joyce AS, O'Kelly JG, Ogrodniczuk JS, Piper WE, Rosie JS.

Psychodyn Psychiatry. 2012 Dec;40(4):645-71. doi: 10.1521/pdps.2012.40.4.645.

PMID:
23216401
15.

Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis.

Chien W, O'Kelly J, Lu D, Leiter A, Sohn J, Yin D, Karlan B, Vadgama J, Lyons KM, Koeffler HP.

Int J Oncol. 2011 Jun;38(6):1741-7. doi: 10.3892/ijo.2011.985. Epub 2011 Mar 23.

16.

Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme.

Yin D, Chen W, O'Kelly J, Lu D, Ham M, Doan NB, Xie D, Wang C, Vadgama J, Said JW, Black KL, Koeffler HP.

Int J Cancer. 2010 Nov 15;127(10):2257-67. doi: 10.1002/ijc.25257.

17.

Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.

Thoennissen NH, O'Kelly J, Lu D, Iwanski GB, La DT, Abbassi S, Leiter A, Karlan B, Mehta R, Koeffler HP.

Oncogene. 2010 Jan 14;29(2):285-96. doi: 10.1038/onc.2009.335. Epub 2009 Oct 26.

PMID:
19855437
18.

Novel acyl sulfonamide LY573636-sodium: effect on hematopoietic malignant cells.

Haritunians T, Gueller S, O'Kelly J, Ilaria R Jr, Koeffler HP.

Oncol Rep. 2008 Nov;20(5):1237-42.

19.

Novel Gemini vitamin D(3) analogs have potent antitumor activity.

Saito T, Okamoto R, Haritunians T, O'Kelly J, Uskokovic M, Maehr H, Marczak S, Jankowski P, Badr R, Koeffler HP.

J Steroid Biochem Mol Biol. 2008 Nov;112(1-3):151-6. doi: 10.1016/j.jsbmb.2008.09.012. Epub 2008 Sep 30.

20.

Saying it in song: music therapy as a carer support intervention.

O'Kelly J.

Int J Palliat Nurs. 2008 Jun;14(6):281-6.

PMID:
18928132
21.

Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.

Wakimoto N, Wolf I, Yin D, O'Kelly J, Akagi T, Abramovitz L, Black KL, Tai HH, Koeffler HP.

Cancer Res. 2008 Sep 1;68(17):6978-86. doi: 10.1158/0008-5472.CAN-07-5675.

22.

Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo.

Wakimoto N, Yin D, O'Kelly J, Haritunians T, Karlan B, Said J, Xing H, Koeffler HP.

Cancer Sci. 2008 Sep;99(9):1793-7. doi: 10.1111/j.1349-7006.2008.00899.x. Epub 2008 Jul 10.

23.

Functional domains of CCN1 (Cyr61) regulate breast cancer progression.

O'Kelly J, Chung A, Lemp N, Chumakova K, Yin D, Wang HJ, Said J, Gui D, Miller CW, Karlan BY, Koeffler HP.

Int J Oncol. 2008 Jul;33(1):59-67.

PMID:
18575751
24.

CYR61: a new measure of lung cancer outcome.

Mori A, Desmond JC, Komatsu N, O'Kelly J, Miller CW, Legaspi R, Marchevsky AM, McKenna RJ Jr, Koeffler HP.

Cancer Invest. 2007 Dec;25(8):738-41.

PMID:
18058471
25.

Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBPbeta-deficient hematopoietic cells.

Akagi T, Saitoh T, O'Kelly J, Akira S, Gombart AF, Koeffler HP.

Blood. 2008 Mar 15;111(6):2999-3004. Epub 2007 Dec 4.

26.

Multidisciplinary perspectives of music therapy in adult palliative care.

O'Kelly J, Koffman J.

Palliat Med. 2007 Apr;21(3):235-41.

PMID:
17641077
27.

Common deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice.

Lehmann S, O'Kelly J, Raynaud S, Funk SE, Sage EH, Koeffler HP.

Leukemia. 2007 Sep;21(9):1931-6. Epub 2007 Jul 12.

PMID:
17625608
28.

Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest.

Wolf I, O'Kelly J, Wakimoto N, Nguyen A, Amblard F, Karlan BY, Arbiser JL, Koeffler HP.

Int J Oncol. 2007 Jun;30(6):1529-37.

PMID:
17487375
29.

Regulation of the CAMP gene by 1,25(OH)2D3 in various tissues.

Gombart AF, O'Kelly J, Saito T, Koeffler HP.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):552-7. Epub 2006 Dec 23.

PMID:
17368184
30.

Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma.

Haritunians T, Mori A, O'Kelly J, Luong QT, Giles FJ, Koeffler HP.

Leukemia. 2007 Feb;21(2):333-9. Epub 2006 Nov 30.

PMID:
17136116
31.

Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.

Luong QT, O'Kelly J, Braunstein GD, Hershman JM, Koeffler HP.

Clin Cancer Res. 2006 Sep 15;12(18):5570-7.

32.

Re: Day treatment for personality disorders.

Rosie J, Joyce A, O'Kelly JG, Steinberg P.

Can J Psychiatry. 2006 Apr;51(5):333. No abstract available.

PMID:
16986823
33.

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

Wolf I, O'Kelly J, Rubinek T, Tong M, Nguyen A, Lin BT, Tai HH, Karlan BY, Koeffler HP.

Cancer Res. 2006 Aug 1;66(15):7818-23.

34.

Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway.

O'Kelly J, Uskokovic M, Lemp N, Vadgama J, Koeffler HP.

J Steroid Biochem Mol Biol. 2006 Aug;100(4-5):107-16. Epub 2006 Jun 14.

PMID:
16777406
35.

Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.

Mori A, Lehmann S, O'Kelly J, Kumagai T, Desmond JC, Pervan M, McBride WH, Kizaki M, Koeffler HP.

Cancer Res. 2006 Mar 15;66(6):3222-9.

36.

Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells.

Müller CI, Kumagai T, O'Kelly J, Seeram NP, Heber D, Koeffler HP.

Leuk Res. 2006 Jul;30(7):841-8. Epub 2006 Jan 19.

PMID:
16423392
37.

BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).

Williamson EA, Wolf I, O'Kelly J, Bose S, Tanosaki S, Koeffler HP.

Oncogene. 2006 Mar 2;25(9):1391-9.

PMID:
16331276
38.

Aberrant expression of neutrophil and macrophage-related genes in a murine model for human neutrophil-specific granule deficiency.

Gombart AF, Krug U, O'Kelly J, An E, Vegesna V, Koeffler HP.

J Leukoc Biol. 2005 Nov;78(5):1153-65. Epub 2005 Oct 4.

PMID:
16204633
39.

Vitamin D(2) analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome.

Koeffler HP, Aslanian N, O'Kelly J.

Leuk Res. 2005 Nov;29(11):1259-62. Epub 2005 Apr 26.

PMID:
16164982
40.

Dlk1 in normal and abnormal hematopoiesis.

Sakajiri S, O'kelly J, Yin D, Miller CW, Hofmann WK, Oshimi K, Shih LY, Kim KH, Sul HS, Jensen CH, Teisner B, Kawamata N, Koeffler HP.

Leukemia. 2005 Aug;19(8):1404-10.

PMID:
15959531
41.

CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.

Ikezoe T, Gery S, Yin D, O'Kelly J, Binderup L, Lemp N, Taguchi H, Koeffler HP.

Cancer Res. 2005 Jun 1;65(11):4762-8.

42.

19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia.

Kumagai T, Shih LY, Hughes SV, Desmond JC, O'Kelly J, Hewison M, Koeffler HP.

Cancer Res. 2005 Mar 15;65(6):2488-97.

43.

The psychodynamic psychiatry service of the University of Alberta Hospital: a thirty year history.

Steinberg PI, Rosie JS, Joyce AS, O'Kelly JG, Piper WE, Lyon D, Bahrey F, Duggal S.

Int J Group Psychother. 2004 Oct;54(4):521-38.

PMID:
15388404
44.

Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis.

Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, Umehara Y, Wano Y, Said JW, Koeffler HP.

Blood. 2005 Jan 1;105(1):376-81. Epub 2004 Sep 2.

45.

Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway.

Tong X, O'Kelly J, Xie D, Mori A, Lemp N, McKenna R, Miller CW, Koeffler HP.

Oncogene. 2004 Jun 17;23(28):4847-55.

PMID:
15077166
46.

Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.

Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP.

Cancer Res. 2004 Mar 15;64(6):1987-96.

48.

Vitamin D analogs and breast cancer.

O'Kelly J, Koeffler HP.

Recent Results Cancer Res. 2003;164:333-48. Review.

PMID:
12899532
49.

Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells.

Kumagai T, O'Kelly J, Said JW, Koeffler HP.

J Natl Cancer Inst. 2003 Jun 18;95(12):896-905.

PMID:
12813173
50.

Ability of potent vitamin D3 analogs to inhibit growth of prostate cancer cells in vivo.

Vegesna V, O'Kelly J, Said J, Uskokovic M, Binderup L, Koeffle HP.

Anticancer Res. 2003 Jan-Feb;23(1A):283-9.

PMID:
12680225

Supplemental Content

Loading ...
Support Center